Carmel, IN, United States of America

Donald Rogers, Jr

This inventor holds 3 USPTO granted patents. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald Rogers, Jr. Retrieved from https://idiyas.com/inventor/donald-rogers-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 124(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Donald Rogers, Jr.

Introduction: Donald Rogers, Jr. is a visionary inventor based in Carmel, Indiana, whose creative mind has led to groundbreaking innovations in various fields.

Latest Patents: Donald Rogers, Jr. holds several patents in the areas of renewable energy technologies, medical devices, and consumer electronics, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Donald Rogers, Jr. has been at the forefront of cutting-edge technological advancements. His contributions have significantly impacted industries such as healthcare, sustainable energy, and communication.

Collaborations: Throughout his career, Donald Rogers, Jr. has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His collaborative spirit has been instrumental in the success of many projects.

Conclusion: Donald Rogers, Jr.'s passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…